CEMQ:XETRA:XETRA-iShares Edge MSCIope Quality Factor UCITS (EUR)

ETF | Others |

Last Closing

USD 10.146

Change

+0.07 (+0.65)%

Market Cap

USD 0.53B

Volume

5.31K

Analyst Target

N/A
Analyst Rating

Verdict

ducovest Verdict

Verdict

About

Unadjusted Closing Price

Adjusted Closing Price

Share Volume

Relative Performance (Total Returns)

Compare
Relative Returns (From:    To: 2024-05-03 )

Largest Industry Peers for Others

Symbol Name Price(Change) Market Cap
XM1D:XETRA Xtrackers MSCI Japan UCITS ETF..

-0.32 (-0.62%)

USD 448.39B
LCUJ:XETRA Lyxor Core MSCI Japan (DR) UCI..

-0.12 (-0.73%)

USD 191.96B
PRAJ:XETRA Amundi Index Solutions - Amund..

-0.20 (-0.74%)

USD 177.46B
PR1J:XETRA Amundi Prime Japan UCITS ETF D..

-0.11 (-0.38%)

USD 177.46B
XDJP:XETRA Xtrackers Nikkei 225 UCITS ETF..

-0.23 (-0.94%)

USD 157.79B
TM5:XETRA T-MOBILE US INC.DL-00001

-0.08 (-0.05%)

USD 126.93B
JARI:XETRA Amundi Index Solutions - Amund..

-0.48 (-1.10%)

USD 102.57B
8R80:XETRA Amundi Index Solutions - Amund..

-1.36 (-0.96%)

USD 102.14B
UIM5:XETRA UBS (Lux) Fund Solutions - MSC..

-0.33 (-0.66%)

USD 85.64B
SXR8:XETRA iShares Core S&P 500 UCITS ETF..

-0.74 (-0.14%)

USD 80.38B

ETFs Containing CEMQ:XETRA

N/A

Market Performance

  Market Performance vs. Industry/Classification (Others) Market Performance vs. Exchange
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain 4.09% 47% F 49% F
Dividend Return N/A N/A N/A N/A N/A
Total Return 4.09% 46% F 49% F
Trailing 12 Months  
Capital Gain 9.14% 50% F 54% F
Dividend Return N/A N/A N/A N/A N/A
Total Return 9.14% 50% F 53% F
Trailing 5 Years  
Capital Gain 50.80% 72% C 73% C
Dividend Return N/A N/A N/A N/A N/A
Total Return 50.80% 72% C 70% C-
Average Annual (5 Year Horizon)  
Capital Gain 9.18% 73% C 70% C-
Dividend Return 9.18% 72% C 68% D+
Total Return N/A 8% B- 6% D-
Risk Return Profile  
Volatility (Standard Deviation) 13.62% 47% F 57% F
Risk Adjusted Return 67.37% 85% B 85% B
Market Capitalization 0.53B 69% C- 61% D-

Annual Financials (EUR)

Quarterly Financials (EUR)

Analyst Rating

Target Price Action Rating Action Analyst Rating Price Date

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:
Superior risk adjusted returns

This stock has performed well, on a risk adjusted basis, compared to its sector peers(for a hold period of at least 12 months) and is in the top quartile.

What to not like:
Below median total returns

The company has under performed its peers on annual average total returns in the past 5 years.

High volatility

The total returns for this company are volatile and above median for its sector over the past 5 years. Make sure you have the risk tolerance for investing in such stock.